Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: Eur J Nucl Med Mol Imaging. 2015 Nov 18;43(4):617–625. doi: 10.1007/s00259-015-3247-7

Table 1.

Properties of the study patient population based on randomization arm.

Characteristic CRT arm
(n=19)		 CRT + TPZ arm
(n=22)
Age
  Median 59 (42–72) 59 (46–77)
Gender
  Male (%) 84 (n=16) 82 (n=18)
Site
  Hypopharynx (%) 0 (n=0) 9 (n=2)
  Larynx (%) 11 (n=2) 14 (n=3)
  Oral cavity (%) 11 (n=2) 9 (n=2)
  Oropharynx (%) 79 (n=15) 68 (n=15)
T stage
  T3–4 (%) 79 (n=15) 82 (n=18)
N stage
  N2–3 (%) 89 (n=17) 86 (n=19)
HPV
  Negative (%) 53 (n=10) 64 (n=14)
PET
  FAZA positive (%) 58 (n=11) 32 (n=7)
  Median MTV (cc) 23.8 (3.8–80.4) 16.7 (3.8–48.0)
  Median HTV (cc) 5.7 (0.0–52.3) 1.8 (0.0–23.8)
  Median fHTV 0.3 (0.0–0.9) 0.1 (0.0–0.6)
  Median FDG SUVmax 10.7 (4.6–21.1) 10.4 (3.2–21.1)
  Median FAZA SUVmax 1.7 (0.9–6.1) 1.6 (0.6–2.4)